Genetic markers can be classified as either prognostic or predictive. Prognostic markers provide information about the likely course of the cancer, including the risk of recurrence and overall survival. Predictive markers, on the other hand, indicate how likely a cancer is to respond to a particular treatment. For instance, the KRAS mutation is a predictive marker for the lack of response to certain treatments in colorectal cancer.
